Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
ANNUAL INCOME RANGE
BANK MODIFICATION
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Company News
Bliss GVS Pharma Ltd
Industry : Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value(
)
506197
INE416D01022
97.2265068
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
BLISSGVS
18.28
1483.09
EPS(TTM)
Face Value(
)
Div & Yield %:
7.7
1
0.35
Back
Quadrant Televentures Ltd
Quadrant Televentures Ltd - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Nov 22,2024
In terms of provisions of Regulations 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform the exchange that the Company has received a Notice from the Debenture Trustee of the Company i.e IDBI Trusteeship Services Limited under Section 13(2) of the Securitisation and Reconstruction of the Financial Assets and Enforcement of Security interest Act 2002.